收藏切换
SLC38A1 drives malignant progression of hepatocellular carcinoma by activating PI3K/AKT signaling via enhanced glutamine uptake
收藏切换
Yuanyuan YANG1, Ping ZHANG1, Peng HU1, Maonian LIU1, Yanjiao OU2
Journal of Army Medical University | 2025, 47(23) : 2922 - 2932
Less
收藏切换
Journal of Army Medical University | 2025, 47(23): 2922-2932
• Basic Medicine •
SLC38A1 drives malignant progression of hepatocellular carcinoma by activating PI3K/AKT signaling via enhanced glutamine uptake
Full
Yuanyuan YANG1, Ping ZHANG1, Peng HU1, Maonian LIU1, Yanjiao OU2
Affiliations
  • 1Digestive Disease Center,Chongqing Hygeia Hospital,Chongqing
  • 2Department of Hepatobiliary,First Affiliated Hospital,Army Medical University (Third Military Medical University),Chongqing,China
Published: 2025-12-15 doi: 10.16016/j.2097-0927.202508018
Outline
收藏切换
Objective

To investigate the mechanism by which SLC38A1 promotes hepatocellular carcinoma (HCC) progression through glutamine transport-mediated activation of the PI3K/AKT signaling pathway.

Methods

Bioinformatics analysis was employed to assess the correlation between SLC38A1 expression and clinicopathological features/prognosis in HCC patients, with functional enrichment analysis of SLC38A1 conducted. SLC38A1 was silenced or over expressed via transfection in Huh-7 cells, with glutamine inhibited using DRP-104 and the PI3K/AKT pathway suppressed using LY294002. Cell viability, proliferation, migration, invasion, and glutamine concentration were evaluated using CCK-8, EdU staining, scratch wound healing assay, Transwell chamber assay, and glutamine assay kits, respectively. PI3K/AKT pathway activity was assessed by Western blotting.

Results

SLC38A1 mRNA and protein levels were significantly higher in HCC tumor tissues than in adjacent normal tissues (P<0.05). HCC patients with high SLC38A1 expression exhibited significantly lower overall survival than those with low expression (P<0.05). SLC38A1 expression correlated significantly with pathologic T-stage (pT), N-stage (pN), M-stage (pM), survival status, and immune infiltration in HCC patients (P<0.05). SLC38A1 silencing markedly reduced glutamine uptake in HCC cells (P<0.001), suppressing cell viability, proliferation, migration, invasion, and PI3K/AKT pathway activity (P<0.001). Conversely, SLC38A1 overexpression promoted proliferation, migration, invasion, and PI3K/AKT activation (P<0.001). DRP-104-mediated glutamine inhibition suppressed HCC cell malignancy and PI3K/AKT signaling while abolishing the oncogenic effects of SLC38A1 overexpression (P<0.001). PI3K/AKT pathway inhibition blocked the pro-tumorigenic effects of SLC38A1 overexpression (P<0.001).

Conclusion

SLC38A1 promotes proliferation, migration, and invasion in HCC by activating the PI3K/AKT pathway through enhanced glutamine transport.

hepatocellular carcinoma  /  glutamine  /  SLC38A1
杨媛媛, 张平, 胡鹏, 刘茂年, 欧晏娇. SLC38A1通过促进谷氨酰胺摄取激活PI3K/AKT信号通路驱动肝细胞癌恶性进展. 陆军军医大学学报, 2025 , 47 (23) : 2922 -2932 . DOI: 10.16016/j.2097-0927.202508018
Yuanyuan YANG, Ping ZHANG, Peng HU, Maonian LIU, Yanjiao OU. SLC38A1 drives malignant progression of hepatocellular carcinoma by activating PI3K/AKT signaling via enhanced glutamine uptake[J]. Journal of Army Medical University, 2025 , 47 (23) : 2922 -2932 . DOI: 10.16016/j.2097-0927.202508018
Year 2025 volume 47 Issue 23
27
11
Cite this Article
BibTeX
Article Info
doi: 10.16016/j.2097-0927.202508018
  • Receive Date:2025-08-07
  • Online Date:2026-10-30
  • Published:2025-12-15
Article Data
Affiliations
History
  • Received:2025-08-07
  • Revised:2025-11-20
Affiliations
    1Digestive Disease Center,Chongqing Hygeia Hospital,Chongqing
    2Department of Hepatobiliary,First Affiliated Hospital,Army Medical University (Third Military Medical University),Chongqing,China
References
Share
https://castjournals.cast.org.cn/joweb/ljjydxxb/EN/10.16016/j.2097-0927.202508018
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT